Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
· cocrystal pharma, inc.
Source Summary
Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026
Advertisement
Summarized daily news